In the immediate wake of news Wednesday that Interactive Intelligence Group Inc. had agreed to be acquired for $1.4 billion, Indianapolis tech leaders bubbled with praise for CEO Don Brown and with enthusiasm for the possible impact on the city.
For the third time in a decade, CEO Jeff Smulyan is making an offer for the outstanding shares of Emmis Communications Corp., which runs radio stations and magazines in Indianapolis and major U.S. markets.
Publicly traded Determine Inc. generated fanfare when it announced it was moving its headquarters here and adding 24 jobs to the 35 already here. But many investors have been betting against it for years.
The nation’s largest mall owner said funds from operations, a key measure of profitability, increased 15.4 percent in the first quarter while tenant rents grew.
The Indianapolis mortgage firm has promoted James Smith to the top spot vacated last year in an abrupt resignation by its founder.
The insurer’s CEO said in January that Anthem should be reaping an addition $3 billion per year in savings on drugs from Express Scripts, which manages its pharmacy benefits.
Despite reporting lower profit in the fourth quarter, the nation’s largest mall owner still posted strong results for the full year.
Cigna Corp., which has agreed to a $48 billion merger with Indianapolis-based Anthem Inc., has committed systemic violations that threatened patients’ health, U.S. regulators say.
The Finish Line Inc.’s disastrous third quarter stemmed from management miscues, a well-worn story that has made some analysts skeptical that incoming CEO, Sam Sato, will usher in better times.
In a scathing letter to directors, Privet Fund LP said accountability is sorely lacking throughout the upper ranks of the company, which has a stock price languishing below $2 a share.
Internet behemoth IAC appears bent on hashing out an acquisition and likely would stage a hostile takeover if Angie’s List resists, market analysts say.
A strong third quarter prompted Simon to boost its earnings forecast and raise its quarterly dividend to $1.60 per share, a 23.1 percent year-over-year increase.
Shares sank 15 percent on Wednesday morning despite an $82,000 profit in the third quarter. New CEO Scott Durchslag told analysts he wanted to increase shareholder value organically rather than pursue a sale or merger.
Analysts have consistently given the Indianapolis-based company some of the lowest ratings among a group of 16 large drugmakers, but Lilly shares have been on a five-year rally.
Analysts say the hiring of Scott Durchslag suggests Angie’s List is intent on a turnaround and not a sale. The new CEO shared his vision Tuesday.
Now with a 9-percent stake, New York-based TCS Capital Management says it’s after multiple board seats and plans to continue discussing options to maximize the firm’s value, including a sale.
A wave of fear triggered by instability in China initially doused U.S. stocks on Monday morning, but then quickly receded by noon.
The retailer reported another lackluster quarter with sales dips in every category except home products. But its shares shot up in trading because the results were better than expected.
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
